GN
NASDAQ · GNTA
Genenta Science S.p.A.
Healthcare · Biotechnology
$0.76
Down-$0.06 (-7.74%)
Updated Sep 18, 2026, 9:12 PM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 31.78M
- P/E ratio
- -3.05
- Dividend yield
- 0.00%
- 52-week range
- $0.55 – $2.58
- Volume
- 40.46K
- Avg. volume
- 666.12K
Price performance
GNTA price history
1M range · 20 trading sessions · Daily adjusted prices
GNTA closed at $0.76 after 20 trading sessions, down 36.13% for the selected period.
- Last close
- $0.76
- Period change
- -36.13%
- Period low
- $0.74
- Period high
- $1.26
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $0.75 | $0.7679 | $0.7199 | $0.76 | 40.46K |
| Sep 16, 2026 | $0.8698 | $0.9233 | $0.713 | $0.7413 | 75.94K |
| Sep 15, 2026 | $0.841 | $0.9047 | $0.8301 | $0.8301 | 54.31K |
| Sep 14, 2026 | $0.82 | $0.8527 | $0.82 | $0.8314 | 127.21K |
| Sep 11, 2026 | $0.9341 | $0.9341 | $0.8402 | $0.8408 | 32.9K |
| Sep 10, 2026 | $0.933 | $0.99 | $0.8602 | $0.8613 | 28.96K |
| Sep 9, 2026 | $0.9891 | $1.00 | $0.82 | $0.8725 | 113.12K |
| Sep 8, 2026 | $0.9603 | $1.00 | $0.9603 | $0.9911 | 38.15K |
| Sep 4, 2026 | $0.9373 | $0.99 | $0.9373 | $0.9601 | 31.64K |
| Sep 3, 2026 | $1.00 | $1.00 | $0.9505 | $0.9505 | 52.24K |
| Sep 2, 2026 | $1.02 | $1.0299 | $0.97 | $0.9781 | 23.45K |
| Sep 1, 2026 | $1.04 | $1.04 | $0.98 | $1.01 | 30.15K |
| Aug 31, 2026 | $1.03 | $1.03 | $0.9999 | $1.02 | 24.78K |
| Aug 28, 2026 | $1.02 | $1.0799 | $1.00 | $1.00 | 58.85K |
| Aug 27, 2026 | $1.13 | $1.1774 | $0.9907 | $0.9907 | 89.75K |
| Aug 26, 2026 | $1.1612 | $1.17 | $1.11 | $1.13 | 41.66K |
| Aug 25, 2026 | $1.15 | $1.20 | $1.10 | $1.15 | 82.79K |
| Aug 24, 2026 | $1.20 | $1.23 | $1.15 | $1.15 | 43.95K |
| Aug 21, 2026 | $1.22 | $1.29 | $1.22 | $1.26 | 28.51K |
| Aug 20, 2026 | $1.2097 | $1.27 | $1.18 | $1.19 | 33.67K |
Latest GNTA news
The latest Smart Investors Daily articles mentioning GNTA.
Stock researchCompany · Financials
Loading stock research…
